A phase 3 study of FP-045 in pulmonary hypertension group 3 patients
Latest Information Update: 19 Jun 2023
At a glance
- Drugs Mirivadelgat (Primary)
- Indications Pulmonary arterial hypertension
- Focus Adverse reactions; Registrational; Therapeutic Use
- 19 Jun 2023 New trial record